This is a StreetInsider.com Premium Only Page

MorphoSys AG (MOR) – StreetInsider.com Reports

Apr 11, 2024 08:40 AM MorphoSys AG's (MOR) Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Mar 22, 2024 02:58 AM MorphoSys AG (MOR) Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis

Mar 14, 2024 03:16 PM Wells Fargo Downgrades MorphoSys AG (MOR) to Equal Weight

Mar 13, 2024 04:03 PM MorphoSys AG (MOR) Tops Q3 EPS by 173c

Feb 8, 2024 05:10 AM UBS Downgrades MorphoSys AG (MOR:GR) (MOR) to Neutral

Feb 7, 2024 02:33 AM Citi Upgrades MorphoSys AG (MOR:GR) (MOR) to Neutral

Feb 6, 2024 03:00 PM JMP Securities Downgrades MorphoSys AG (MOR) to Market Perform

Feb 6, 2024 04:06 AM Citi Downgrades MorphoSys AG (MOR) to Neutral

Feb 5, 2024 05:17 PM MorphoSys AG (MOR) to be Acquired by Novartis for EUR 2.7B Equity Value

Feb 5, 2024 04:58 PM After-hours movers: Palantir, NXP Semiconductors and more

Feb 5, 2024 04:49 PM Novartis (NVS) to acquire MorphoSys (MOR) for EUR 68 per share, EUR 2.7bn in cash

Feb 5, 2024 04:46 PM Incyte (INCY) Acquires Rights to Tafasitamab from MorphoSys (MOR)

Feb 5, 2024 11:47 AM Midday movers: Estee Lauder, Eli Lilly and more

Feb 5, 2024 11:33 AM Exclusive-Novartis in the lead to acquire cancer drug developer MorphoSys-sources

Feb 5, 2024 11:28 AM MorphoSys shares soar on report Novartis is in advanced talks to acquire the company

Feb 5, 2024 10:18 AM Novartis (NVS) in Advanced Talks to Acquire Morphosys (MOR), Prevails over Incyte (INCY) - Reuters

Jan 30, 2024 05:42 AM MorphoSys AG (MOR) Reports Prelim 2023 Monjuvi US Sales of $92M, Issues Guidance

Jan 26, 2024 11:23 AM MorphoSys AG (MOR) gains on takeover rumors

Jan 16, 2024 09:55 AM Increasing unusual put option volume: NTR ICLN WULF SPWR AZN EQNR MOR BITF

Jan 16, 2024 05:02 AM Morgan Stanley Downgrades MorphoSys AG (MOR:GR) (MOR) to Equalweight

Dec 15, 2023 07:40 AM MorphoSys AG (MOR) PT Raised to $17 at Wells Fargo

Dec 14, 2023 05:10 AM MorphoSys (MOR) and Ocular Therapeutix (OCUL) shares plunged today. Here's why

Dec 13, 2023 05:35 PM After-hours movers: Adobe sinks following results, Alector gains on upgrade

Dec 13, 2023 05:31 PM MorphoSys AG (MOR) board approves cash capital increase

Dec 11, 2023 03:47 AM MorphoSys (MOR) Reports Pelabresib Improved All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

Dec 5, 2023 07:21 AM MorphoSys AG (MOR) PT Lowered to $8.50 at JPMorgan

Dec 5, 2023 02:21 AM MorphoSys AG (MOR:GR) (MOR) PT Lowered to EUR31 at JPMorgan

Nov 27, 2023 03:58 AM MorphoSys AG (MOR:GR) (MOR) PT Lowered to EUR15 at Citi

Nov 22, 2023 06:51 AM MorphoSys AG (MOR:GR) (MOR) PT Lowered to EUR17.50 at Goldman Sachs

Nov 20, 2023 04:30 PM MorphoSys AG (MOR) Reports Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction

Nov 20, 2023 04:26 PM MorphoSys AG (MOR) Halted, News Pending

Nov 15, 2023 04:03 PM MorphoSys AG (MOR) Misses Q2 EPS by 292c

Oct 31, 2023 05:41 AM MorphoSys AG (MOR:GR) (MOR) PT Raised to EUR26 at Citi

Oct 25, 2023 05:32 AM MorphoSys AG (MOR) Reports Prelim Q3 Monjuvi U.S. Sales of $23.4M, Updates Guidance for 2023

Oct 17, 2023 01:26 PM Hedge Fund Caligan Partners' Johnson Says MorphoSys Stock Could Trade at 60 Euros a Share Within Weeks

Oct 13, 2023 03:36 AM Morgan Stanley Upgrades MorphoSys AG (MOR) to Overweight

Oct 13, 2023 03:36 AM Morgan Stanley Upgrades MorphoSys AG (MOR:GR) (MOR) to Overweight

Sep 15, 2023 02:49 AM Goldman Sachs Upgrades MorphoSys AG (MOR:GR) (MOR) to Neutral

Sep 15, 2023 02:49 AM Goldman Sachs Upgrades MorphoSys AG (MOR) to Neutral

Sep 12, 2023 04:54 PM MorphoSys AG (MOR) Granted FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer

Aug 13, 2023 11:34 AM MorphoSys AG (MOR) PT Raised to $3.70 at Morgan Stanley

Aug 9, 2023 04:28 PM MorphoSys AG (MOR) Tops Q1 EPS by 13c

Jul 27, 2023 02:07 AM MorphoSys AG (MOR:GR) (MOR) PT Raised to EUR23 at Citi

Jun 16, 2023 07:09 AM JPMorgan Upgrades MorphoSys AG (MOR) to Overweight

Jun 16, 2023 05:33 AM Wells Fargo Resumes MorphoSys AG (MOR) at Overweight

Jun 16, 2023 01:52 AM JPMorgan Upgrades MorphoSys AG (MOR:GR) (MOR) to Overweight

May 31, 2023 02:43 AM UBS Starts MorphoSys AG (MOR:GR) (MOR) at Buy

May 9, 2023 04:06 AM MorphoSys AG (MOR) PT Raised to $3.50 at Morgan Stanley

May 9, 2023 04:03 AM MorphoSys AG (MOR:GR) (MOR) PT Raised to EUR13.50 at Morgan Stanley

May 9, 2023 03:40 AM MorphoSys AG (MOR:GR) (MOR) PT Raised to EUR14 at Citi